Hims & Hers Health Launches Low Testosterone Treatments on Telehealth Platform
Hims & Hers Health announced the launch of new treatments for low testosterone through its telehealth platform. The company is expanding into this area to address a common health issue among men in the United States.
The new offerings include personalized and affordable treatment plans, including a branded oral testosterone medication. An estimated twenty million men in the U.S. are affected by low testosterone, which can contribute to reduced energy, lower mood and sexual desire, and increased health risks like heart disease and diabetes if left untreated.
With these new services, Hims & Hers Health aims to make it easier for men to access care for low testosterone and overcome the stigma that sometimes surrounds this health concern. The launch led to a rise in Hims & Hers Health's stock price following the announcement.
Low testosterone is a medical condition where the body does not produce enough of the hormone testosterone, which can lead to symptoms such as low energy, poor mood, reduced sexual desire, and health complications.
Hims & Hers now offers telehealth consultations and personalized treatment plans, making it easier for men to get help and treatment for low testosterone without visiting a clinic in person.
The launch allows Hims & Hers to address a widespread health issue and expand its services, which may benefit both customers and the company's business.
WSJ
Business Wire
Reuters
Benzinga
Investors Business Daily
Seeking Alpha